444685
Platinum
wire, diam. 2.0 mm, 99.9% trace metals basis
Synonym(s):
Platinum black, Platinum element, Platinum gray
Sign Into View Organizational & Contract Pricing
All Photos(1)
About This Item
Empirical Formula (Hill Notation):
Pt
CAS Number:
Molecular Weight:
195.08
EC Number:
MDL number:
UNSPSC Code:
12141734
PubChem Substance ID:
NACRES:
NA.23
Recommended Products
Quality Level
Assay
99.9% trace metals basis
form
wire
resistivity
10.6 μΩ-cm, 20°C
diam.
2.0 mm
bp
3827 °C (lit.)
mp
1772 °C (lit.)
density
21.45 g/cm3 (lit.)
SMILES string
[Pt]
InChI
1S/Pt
InChI key
BASFCYQUMIYNBI-UHFFFAOYSA-N
Related Categories
General description
Platinum (Pt) wire is a metal wire that is a biocompatible material that can be used in electrodes and implants. The efficiency of the platinum electrode can be improved by forming a platinum black surface.
Quantity
1.4 g = 2 cm; 7 g = 10 cm
Storage Class Code
13 - Non Combustible Solids
WGK
nwg
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Customers Also Viewed
Synthesis of novel ruthenium sensitizers and their application in dye-sensitized solar cells
Nazeeruddin MK, et al.
Coordination Chemistry Reviews, 249(13-14), 1460-1467 (2005)
Electrodes
Bioimpedance and Bioelectricity Basics, 179-254 (2015)
Electrode array design and fabrication for implantable systems
Implantable Sensor Systems for Medical Applications, 249(13-14), 150-182 (2013)
Tao Xiong et al.
Journal of biomedical nanotechnology, 9(2), 274-280 (2013-05-01)
Noninvasive molecular fluorescence imaging in vivo which combines Optical imaging with genetic marker technology can real time monitor the development of tumor, through the use of human adenoid cystic carcinoma cell (ACC-M) and lung carcinoma cells SPC-A1 were thansfected by
Hiroaki Akamatsu et al.
Japanese journal of clinical oncology, 43(6), 664-668 (2013-04-16)
Interstitial lung disease associated with gefitinib is a critical adverse reaction. When geftinib was administered to EGFR-unknown patients, the interstitial lung disease incidence rate was approximately 3-4% in Japan, and usually occurs during the first 4 weeks of treatment. However
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service